EU OKs X-Excite sublingual trial against Viagra; SurModics searches for 'secret sauce';

> The European Union's regulatory body has approved a trial by Global Health Ventures for the sulingual version of its X-Excite drug for erectile dysfunction. The trial will compare X-Excite with Pfizer's Viagra. Global Health Ventures release

> Drug-delivery company SurModics, fresh from a standoff with activist shareholder Ramius and a management shakeup, is still searching for its "secret sauce." The Minnesota company is not saying what that might be, but there is speculation that it will not involve pharmaceuticals. Story

> The American Association of Pharmaceutical Scientists is sponsoring an annual award to acknowledge excellence in graduate-level research on lipid excipients in development of oral and topical drug delivery systems. Deadline is May 11. Announcement

Drug delivery patent application of the week: Drug delivery system for administration of poorly water soluble pharmaceutically active substances Patent application

And Finally... When is a straw a drug-delivery system? When it's for kids, of course. Report

Suggested Articles

The new digital Abilify is a breakthrough for Proteus Digital Health and its patient-tracking products, but not so much for Abilify's maker, Otsuka.

Adamis Pharmaceuticals' EpiPen contender Symjepi, which was rejected last year before the EpiPen havoc, won approval from the FDA.

Researchers in the U.K. have developed a technique to better predict results in liver cancer when drug-laden polymer beads are used to deliver medicines.